Host defense peptides as new weapons in cancer treatment (original) (raw)

Abstract.

In the last decade intensive research has been conducted to determine the role of innate immunity host defense peptides (also termed antimicrobial peptides) in the killing of prokaryotic and eukaryotic cells. Many antimicrobial peptides damage the cellular membrane as part of their killing mechanism. However, it is not clear what makes cancer cells more susceptible to some of these peptides, and what the molecular mechanisms underlying these activities are. Two general mechanisms were suggested: (i) plasma membrane disruption via micellization or pore formation, and (ii) induction of apoptosis via mitochondrial membrane disruption. To be clinically used, these peptides need to combine high and specific anticancer activity with stability in serum. Although so far very limited, new studies have paved the way for promising anticancer host defense peptides with a new mode of action and with a broad spectrum of anticancer activity.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, 76100, Israel
    N. Papo & Y. Shai

Authors

  1. N. Papo
    You can also search for this author inPubMed Google Scholar
  2. Y. Shai
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toY. Shai.

Additional information

Received 21 December 2004; received after revision 28 January 2005; accepted 1 February 2005

Rights and permissions

About this article

Cite this article

Papo, N., Shai, Y. Host defense peptides as new weapons in cancer treatment.CMLS, Cell. Mol. Life Sci. 62, 784–790 (2005). https://doi.org/10.1007/s00018-005-4560-2

Download citation

Key words.